Original release date: February 4, 2020
Access to this course expires on: October 17, 2022 at 11:59 PM Pacific Time
Diagnostic gastrointestinal pathology is experiencing dynamic, fluid changes that require the attention of surgical pathologists who specialize in this area or who sign-out biopsies from the GI tract and liver. There are updates in the AJCC staging of mucinous neoplasms of the appendix and conceptual changes in interpreting appendectomy samples containing luminal and extra-appendiceal mucin; there is confusion about the diagnosis and outcome of so-called goblet cell carcinoid, and a new classification scheme is available; Barrett's esophagus is often over-diagnosed but a new method informs separation of reactive changes from low-grade and indefinite dysplasia; spindle cell tumors can be separated morphologically and by their molecular features; overlapping patterns of injury are encountered in disease and iatrogenic conditions, but can be separated; liver pathology has become more challenging in the context of treatment for Hepatitis C; certain infections maybe mistaken for inflammatory disease, requiring criteria for identification and diagnosis. This faculty derived from the Rodger C. Haggitt Gastrointestinal Pathology Society (GIPS) is poised to provide the latest information in these challenging areas in a unique mentoring environment.
Practicing academic and community pathologists, and pathologists-in-training
Upon completion of this educational activity, learners will be able to:
- Recognize several types of appendiceal lesions and their biologic potential
- Compare features of several types of gastrointestinal and hepatic lesions to their mimics
- Understand the morphology and biology ofseveral types of gastrointestinal spindle cell lesions
- Comprehend key features that separate reactive columnar cell proliferations from dysplasia
- Assess endoscopic resection samples
Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the United States and Canadian Academy of Pathology and the Gastrointestinal Pathology Society. The United States and Canadian Academy of Pathology is accredited by the ACCME to provide continuing medical education for physicians.
The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 11.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Beginning in 2021, the American Board of Pathology (ABPath) will no longer require Self-Assessment Modules (SAMs) for Part II Lifelong Learning of the Continuing Certification program. For additional information, visit the ABPath website.
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. USCAP has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.
The following faculty reported no relevant financial relationships: Elizabeth Montgomery, MD, Teri A. Longacre, MD, Joseph Misdraji, MD, Meredith Pittman, MD, MSCI
The following IM Coordinator who planned and reviewed content for this activity reported no relevant financial relationships: Rhonda K. Yantiss, MD and Steven D. Billings, MD
USCAP staff associated with the development of content for this activity reported no relevant financial relationships.
To earn CME credit, all learners must complete the evaluation. View and print your certificate by clicking here.
Buy the entire Oasis of Gastrointestinal Pathology course and get a great discount!
Not A Member? Click Here